251 related articles for article (PubMed ID: 27716070)
1. A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio.
Ucar FM
BMC Cardiovasc Disord; 2016 Oct; 16(1):186. PubMed ID: 27716070
[TBL] [Abstract][Full Text] [Related]
2. The Relationship Between Lymphocyte-to-Monocyte Ratio and Bare-Metal Stent In-Stent Restenosis in Patients With Stable Coronary Artery Disease.
Murat SN; Yarlioglues M; Celik IE; Kurtul A; Duran M; Kilic A; Oksuz F
Clin Appl Thromb Hemost; 2017 Apr; 23(3):235-240. PubMed ID: 26759373
[TBL] [Abstract][Full Text] [Related]
3. Monocyte to HDL ratio in prediction of BMS restenosis in subjects with stable and unstable angina pectoris.
Tok D; Turak O; Yayla Ç; Ozcan F; Tok D; Çağlı K
Biomark Med; 2016 Aug; 10(8):853-60. PubMed ID: 27415579
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
Turak O; Canpolat U; Özcan F; Mendi MA; Oksüz F; Işleyen A; Gürel OM; Çay S; Aras D; Aydoğdu S
Am J Cardiol; 2014 Jan; 113(2):197-202. PubMed ID: 24157191
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis.
Yilmaz S; Akboga MK; Sen F; Balcı KG; Aras D; Temizhan A; Aydogdu S
Biomark Med; 2016 Sep; 10(9):959-66. PubMed ID: 27537215
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis.
Yılmaz S; Sen F; Ünal S; Yayla C; Özeke Ö; Aras D; Topaloglu S; Aydogdu S
Scand Cardiovasc J; 2015 Feb; 49(1):39-44. PubMed ID: 25414124
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the Correlation Between the Ratio of Monocytes to High-Density Lipoprotein Cholesterol and in-Stent Restenosis in Patients with Premature Coronary Heart Disease.
Chen BW; Liu JJ; Xing JH; Liu HD; Wei YZ; Xue XF; Gu HP; Tao HL
Clin Appl Thromb Hemost; 2022; 28():10760296221079334. PubMed ID: 35187964
[TBL] [Abstract][Full Text] [Related]
8. Preinterventional peak monocyte count and in-stent intimal hyperplasia after coronary stent implantation in human coronary arteries.
Hong YJ; Jeong MH; Lim SY; Lee SR; Kim KH; Sohn IS; Park HW; Kim JH; Kim W; Ahn Y; Cho JG; Park JC; Kang JC
Clin Cardiol; 2005 Nov; 28(11):512-8. PubMed ID: 16450794
[TBL] [Abstract][Full Text] [Related]
9. Impact of free thyroxine levels and other clinical factors on bare metal stent restenosis.
Canpolat U; Turak O; Özcan F; Öksüz F; Mendi MA; Yayla Ç; Aydoğdu S
Arch Endocrinol Metab; 2017; 61(2):130-136. PubMed ID: 28489156
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis.
Turak O; Ozcan F; Isleyen A; Tok D; Sokmen E; Buyukkaya E; Aydogdu S; Akpek M; Kaya MG
Am J Cardiol; 2012 Nov; 110(10):1405-10. PubMed ID: 22858185
[TBL] [Abstract][Full Text] [Related]
11. Blood level of CD45+ platelets and development of restenosis after drug-eluting stent implantation in patients with stable coronary artery disease.
Gabbasov Z; Kozlov S; Byazrova S; Saburova O; Melnikov I; Caprnda M; Curilla E; Gaspar L; Kruzliak P; Smirnov V
Wien Klin Wochenschr; 2016 Dec; 128(23-24):898-905. PubMed ID: 27637207
[TBL] [Abstract][Full Text] [Related]
12. Role of Gene Polymorphisms/Haplotypes and Plasma Level of TGF-β1 in Susceptibility to In-Stent Restenosis Following Coronary Implantation of Bare Metal Stent in Chinese Han Patients.
Chen HJ; Mo N; Zhang YF; Su GZ; Wu HD; Pei F
Int Heart J; 2018 Jan; 59(1):161-169. PubMed ID: 29332922
[TBL] [Abstract][Full Text] [Related]
13. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
Yildiz A; Tekiner F; Karakurt A; Sirin G; Duman D
Coron Artery Dis; 2014 Sep; 25(6):469-73. PubMed ID: 24614629
[TBL] [Abstract][Full Text] [Related]
14. Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis.
Drozd J; Wójcik J; Małek R; Korona B; Zapolski T; Wysokiński A
Kardiol Pol; 2010 Jun; 68(6):637-45. PubMed ID: 20806192
[TBL] [Abstract][Full Text] [Related]
15. Preprocedural Albumin Levels and Risk of In-Stent Restenosis After Coronary Stenting With Bare-Metal Stent.
Celik IE; Yarlioglues M; Kurtul A; Duran M; Koseoglu C; Oksuz F; Aksoy O; Murat SN
Angiology; 2016 May; 67(5):478-83. PubMed ID: 26243483
[TBL] [Abstract][Full Text] [Related]
16. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease.
Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Akyel A; Mendi MA; Oksuz F
Platelets; 2015; 26(1):48-52. PubMed ID: 24831828
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents.
Kurtul A
Clin Appl Thromb Hemost; 2018 May; 24(4):589-595. PubMed ID: 28675046
[TBL] [Abstract][Full Text] [Related]
18. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease.
Yoshimura M; Umemoto S; Kawano R; Hiromoto M; Yamada M; Fujimura T; Tanaka M; Nao T; Miura T; Yano M
Int Heart J; 2021; 62(5):970-979. PubMed ID: 34588411
[TBL] [Abstract][Full Text] [Related]
19. Association of serum procalcitonin level with in-stent restenosis in patients undergoing bare-metal stent implantation.
Ornek E; Cetin M; Kiziltunc E; Kurtul A; Gok M; Kundi H
Biomark Med; 2018 May; 12(5):455-463. PubMed ID: 29517279
[TBL] [Abstract][Full Text] [Related]
20. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
